Speaker(s): 

Gretchen Urban, MS, LCGC, Genetic Counselor II, Geisinger (Has nothing to disclose) 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Provide a brief overview of inborn errors of metabolism (IEMs)
• Define current treatment strategies for IEMs, emphasizing Enzyme Replacement Therapy (ERT)  
• Describe ERT for those with Fabry disease  
• Report on MyCode GSC patients with Fabry disease who receive or could receive ERT

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Adam Buchanan, MS, MPH, LCGC, Juliann Savatt, MS, LCGC, Melissa Kelly, MS, LCGC, Marc Williams, MD, and Cara McCormick, MPH have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None